Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to -$11.1 million.

  • Pulse Biosciences' Net Cash Flow fell 12107.42% to -$11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.2 million, marking a year-over-year decrease of 4351.59%. This contributed to the annual value of $73.7 million for FY2024, which is 53920.95% up from last year.
  • As of Q3 2025, Pulse Biosciences' Net Cash Flow stood at -$11.1 million, which was down 12107.42% from -$12.9 million recorded in Q2 2025.
  • In the past 5 years, Pulse Biosciences' Net Cash Flow ranged from a high of $54.4 million in Q3 2022 and a low of -$15.9 million during Q1 2022
  • Over the past 5 years, Pulse Biosciences' median Net Cash Flow value was -$7.0 million (recorded in 2023), while the average stood at $4.4 million.
  • Over the last 5 years, Pulse Biosciences' Net Cash Flow had its largest YoY gain of 481398.96% in 2021, and its largest YoY loss of 34804.38% in 2021.
  • Pulse Biosciences' Net Cash Flow (Quarter) stood at -$13.4 million in 2021, then surged by 40.02% to -$8.0 million in 2022, then grew by 24.95% to -$6.0 million in 2023, then skyrocketed by 747.82% to $39.0 million in 2024, then tumbled by 128.55% to -$11.1 million in 2025.
  • Its Net Cash Flow stands at -$11.1 million for Q3 2025, versus -$12.9 million for Q2 2025 and $1.2 million for Q1 2025.